supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 8 months ago
Research Papers that Mention the Interaction
“Two weeks of continuous axitinib exposure led to decreases in V b (median -21%, P = 0.07), K 1 (median -39%, P < 0.01), and K i (median -37%, P < 0.01), corresponding to diminished tumor vasculature and cell proliferation that may antagonize treatment with concurrent chemotherapy.”
Dynamic 18F-FLT PET imaging of spatiotemporal changes in tumor cell proliferation and vasculature reveals the mechanistic actions of anti-angiogenic therapy.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback